揭开本拉利祖马布在重症酸性喘中的长期有效性:为期三年的现实研究
Laura Pini1,2, Diego Bagnasco3, Bianca Beghè4
1ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Journal of clinical medicine
|May 25, 2024
概括
在36个月的时间里,本拉利祖马布显著降低了严重酸性喘 (SEA) 患者的恶化并改善了肺功能. 治疗也导致了高临床缓解率和减少药物使用,支持其疾病修饰潜力.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的酸性喘 (SEA) 需要有效的长期管理策略.
- 有限的数据存在于本拉利祖马布在SEA的有效性超过两年.
- 贝纳利祖马布向的是介素-5受体α子单元.
研究的目的:
- 评估本拉利祖马布在SEA患者长达36个月的长期疗效.
- 评估临床缓解率和药物使用的变化.
- 分析同病性CRSwNP患者对鼻腔症状的影响.
主要方法:
- 对108名意大利SEA患者进行了回顾性多中心研究.
- 用本拉利祖马布治疗的持续时间可达36个月.
- 包括恶化率,FEV1和临床缓解的混合效应回归模型在内的统计分析.
主要成果:
- 本拉利祖马布在36个月后将恶化率降低了89%.
- 在1秒内强制呼气量 (FEV1) 增加了440毫升 (p < 0.0001).
- 84.31%的患者实现了部分或完全的临床缓解;OCS使用显著减少.
结论:
- 贝纳利祖马布在改善喘和鼻腔结局方面表现出持续的有效性,长达36个月.
- 该药物具有诱导SEA临床缓解的潜力,作为疾病修饰剂.
- 需要进一步的研究来确认长期的安全性,并尽量减少数据丢失.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
273
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
273
Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
Antiasthma Drugs: β2-Adrenoceptor Agonists
250
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
250
Drugs Used in Lower Respiratory Disorders: Overview
421
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
421
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236


